Yonsei medical journal

• Latest
• Best
• Search…

• Yonsei medical journal · Jun 2022

  MiR-103a-3p Contributes to the Progression of Colorectal Cancer by Regulating GREM2 Expression.

  Our research aimed to investigate the influence of miR-103a-3p on the growth and apoptosis of colorectal cancer (CRC) cells. ⋯ MiR-103a-3p could augment CRC progression by targeting GREM2 and that miR-103a-3p/GREM2 could be potential novel targets for CRC therapy.

  read on… or not…

• Yonsei medical journal · Jun 2022

  Fimasartan Ameliorates Deteriorations in Glucose Metabolism in a High Glucose State by Regulating Skeletal Muscle and Liver Cells.

  Since diabetes and hypertension frequently occur together, it is thought that these conditions may have a common pathogenesis. This study was designed to evaluate the anti-diabetic function of the anti-hypertensive drug fimasartan on C2C12 mouse skeletal muscle and HepG2 human liver cells in a high glucose state. ⋯ In conclusion, fimasartan ameliorates deteriorations in glucose metabolism as a result of a high glucose state by regulating PPARδ in skeletal muscle and liver cells.

  read more… or not…

• Yonsei medical journal · Jun 2022

  Erratum to "Angiopoietin-1 Modified Human Umbilical Cord Mesenchymal Stem Cell Therapy for Endotoxin-Induced Acute Lung Injury in Rats" by Huang ZW, et al. (Yonsei Med J 2017 Jan;58(1):206-216.).

  This corrects the article on p. 206 in vol. 58, PMID: 27873515.

  explore more… or not…